Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis , , ,

Kotronen, 2008, Fatty liver: a novel component of the metabolic syndrome, Arterioscler Thromb Vasc Biol, 28, 27, 10.1161/ATVBAHA.107.147538

Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 55, 2005, 10.1002/hep.25762

Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 346, 1221, 10.1056/NEJMra011775

Cohen, 2011, Human fatty liver disease: old questions and new insights, Science, 332, 1519, 10.1126/science.1204265

Zivkovic, 2007, Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease, Am J Clin Nutr, 86, 285, 10.1093/ajcn/86.2.285

Shoelson, 2006, Inflammation and insulin resistance, J Clin Invest, 116, 1793, 10.1172/JCI29069

Narasimhan, 2010, Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes, Clin Biochem, 43, 815, 10.1016/j.clinbiochem.2010.04.003

McCullough, 2004, The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease, Clinics in Liver Disease, 8, 521, 10.1016/j.cld.2004.04.004

Bedogni, 2006, The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population, BMC Gastroenterol, 6, 33, 10.1186/1471-230X-6-33

Bedogni, 2010, A simple index of lipid overaccumulation is a good marker of liver steatosis, BMC Gastroenterol, 10, 988, 10.1186/1471-230X-10-98

Vernon, 2011, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Aliment Pharmacol Ther, 34, 274, 10.1111/j.1365-2036.2011.04724.x

Welsh, 2013, Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010, J Pediatr, 162, 496, 10.1016/j.jpeds.2012.08.043

Younossi, 2011, Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008, Clin Gastroenterol Hepatol, 9, 524, 10.1016/j.cgh.2011.03.020

White, 2013, Challenging the fructose hypothesis: new perspectives on fructose consumption and metabolism, Adv Nutr, 4, 246, 10.3945/an.112.003137

Lustig, 2010, Fructose: metabolic, hedonic, and societal parallels with ethanol, J Am Diet Assoc, 110, 1307, 10.1016/j.jada.2010.06.008

Montonen, 2007, Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence, J Nutr, 137, 1447, 10.1093/jn/137.6.1447

Ackerman, 2005, Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction, Hypertension, 45, 1012, 10.1161/01.HYP.0000164570.20420.67

Armutcu, 2005, Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats, Clin Biochem, 38, 540, 10.1016/j.clinbiochem.2005.01.013

Davail, 2005, Effects of dietary fructose on liver steatosis in overfed mule ducks, Horm Metab Res, 37, 32, 10.1055/s-2005-861029

Kawasaki, 2009, Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis, J Nutr, 139, 2067, 10.3945/jn.109.105858

Takahashi, 2012, Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World journal of gastroenterology, World J Gastroenterol, 18, 2300, 10.3748/wjg.v18.i19.2300

Bray, 2004, Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity, Am J Clin Nutr, 79, 537, 10.1093/ajcn/79.4.537

Welsh, 2011, Consumption of added sugars is decreasing in the United States, Am J Clin Nutr, 94, 726, 10.3945/ajcn.111.018366

Russell, 2009, Opportunities and challenges in conducting systematic reviews to support the development of nutrient reference values: vitamin A as an example, Am J Clin Nutr, 89, 728, 10.3945/ajcn.2008.27154

2011

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097

Sievenpiper, 2012, Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis, Ann Intern Med, 156, 291, 10.7326/0003-4819-156-4-201202210-00007

Wang, 2012, The effects of fructose intake on serum uric acid vary among controlled dietary trials, J Nutr, 142, 916, 10.3945/jn.111.151951

Sievenpiper, 2012, ’Catalytic’ doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials, Br J Nutr, 108, 418, 10.1017/S000711451200013X

Ha, 2012, Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials, Hypertension, 59, 787, 10.1161/HYPERTENSIONAHA.111.182311

Sievenpiper, 2009, Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans, Diabetes Care, 32, 1930, 10.2337/dc09-0619

Lichtenstein, 2008, Application of systematic review methodology to the field of nutrition, J Nutr, 138, 2297, 10.3945/jn.108.097154

Higgins, 2011, The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials, BMJ, 343, 10.1136/bmj.d5928

Chung, 2009, Vitamin D and calcium: a systematic review of health outcomes, Evid Rep Technol Assess (Full Rep), 183, 1

Well G, Shea B, O’Connel D, Peterson J, Welch V, Bosos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. 2011. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (cited 3 July 2014).

2014

Dahabreh, 2011, Emerging magnetic resonance imaging technologies for musculoskeletal imaging under loading stress: scope of the literature, Ann Intern Med, 155, 616, 10.7326/0003-4819-155-9-201111010-00009

DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2

Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from: www.cochrane-handbook.org.

Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557

Ouyang, 2008, Fructose consumption as a risk factor for non-alcoholic fatty liver disease, J Hepatol, 48, 993, 10.1016/j.jhep.2008.02.011

Thuy, 2008, Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake, J Nutr, 138, 1452, 10.1093/jn/138.8.1452

Volynets, 2012, Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD), Dig Dis Sci, 57, 1932, 10.1007/s10620-012-2112-9

Davis, 2010, Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption, Am J Clin Nutr, 92, 1522, 10.3945/ajcn.2010.30185

Mager, 2010, Dietary and physical activity patterns in children with fatty liver, Eur J Clin Nutr, 64, 628, 10.1038/ejcn.2010.35

Aeberli, 2011, Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial, Am J Clin Nutr, 94, 479, 10.3945/ajcn.111.013540

Koh, 1988, Effects of fructose feeding on blood parameters and blood pressure in impaired glucose-tolerant subjects, J Am Diet Assoc, 88, 932, 10.1016/S0002-8223(21)07931-1

Ngo Sock, 2010, Effects of a short-term overfeeding with fructose or glucose in healthy young males, Br J Nutr, 103, 939, 10.1017/S0007114509992819

Silbernagel, 2012, Cholesterol synthesis is associated with hepatic lipid content and dependent on fructose/glucose intake in healthy humans, Exp Diabetes Res, 2012, 361863, 10.1155/2012/361863

Silbernagel, 2011, Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial, Br J Nutr, 106, 79, 10.1017/S000711451000574X

Stanhope, 2009, Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans, J Clin Invest, 119, 1322, 10.1172/JCI37385

Al-Waili, 2003, Effects of daily consumption of honey solution on hematological indices and blood levels of minerals and enzymes in normal individuals, J Med Food, 6, 135, 10.1089/109662003322233549

Couchepin, 2008, Markedly blunted metabolic effects of fructose in healthy young female subjects compared with male subjects, Diabetes Care, 31, 1254, 10.2337/dc07-2001

Lê K, 2009, Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes, Am J Clin Nutr, 89, 1760, 10.3945/ajcn.2008.27336

Faeh, 2005, Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men, Diabetes, 54, 1907, 10.2337/diabetes.54.7.1907

Lê, 2006, A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans, Am J Clin Nutr, 84, 1374, 10.1093/ajcn/84.6.1374

Perez-Pozo, 2010, Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response, Int J Obes (Lond), 34, 454, 10.1038/ijo.2009.259

Sobrecases, 2010, Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men, Diabetes Metab, 36, 244, 10.1016/j.diabet.2010.03.003

Bravo, 2013, Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles, Appl Physiol Nutr Metab, 38, 681, 10.1139/apnm-2012-0322

Kelsay, 1974, Diets high in glucose or sucrose and young women, Am J Clin Nutr, 27, 926, 10.1093/ajcn/27.9.926

Maersk, 2012, Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study, Am J Clin Nutr, 95, 283, 10.3945/ajcn.111.022533

Porikos, 1983, Diet-induced changes in serum transaminase and triglyceride levels in healthy adult men. Role of sucrose and excess calories, Am J Med, 75, 624, 10.1016/0002-9343(83)90444-8

Purkins, 2004, The influence of diet upon liver function tests and serum lipids in healthy male volunteers resident in a phase I unit, Br J Clin Pharmacol, 57, 199, 10.1046/j.1365-2125.2003.01969.x

Theytaz, 2012, Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans, Am J Clin Nutr, 96, 1008, 10.3945/ajcn.112.035139

Vos, 2009, Fructose and oxidized low-density lipoprotein in pediatric nonalcoholic fatty liver disease: a pilot study, Arch Pediatr Adolesc Med, 163, 674, 10.1001/archpediatrics.2009.93

Goletzke, 2013, Carbohydrate quality is not associated with liver enzyme activity and plasma TAG and HDL concentrations over 5 years in an older population, Br J Nutr, 110, 918, 10.1017/S0007114512005867

Johnston, 2013, No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men, Gastroenterology, 145, 1016, 10.1053/j.gastro.2013.07.012

Cox, 2012, Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans, Nutr Metab (Lond), 9, 68, 10.1186/1743-7075-9-68

Volynets, 2013, A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study, Eur J Nutr, 52, 527, 10.1007/s00394-012-0355-z

Cuthbertson DJ, Irwin A, Pugh CJ, Jones H, Sprung VS, Daousi C, Adams VL, Bimson WE, Shojaee-Moradie F, Umpleby AM et al Ectopic lipid storage in Non-Alcoholic Fatty Liver Disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscle. Clin Sci (Epub ahead of print 16 April 2014).

Johnston, 1999, Special considerations in interpreting liver function tests, Am Fam Physician, 59, 2223

Thapa, 2007, Liver function tests and their interpretation, Indian J Pediatr, 74, 663, 10.1007/s12098-007-0118-7

Chiu, 2014, Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials, Eur J Clin Nutr, 68, 416, 10.1038/ejcn.2014.8

Sanyal, 2011, NASH: a global health problem, Hepatol Res, 41, 670, 10.1111/j.1872-034X.2011.00824.x

Torres, 2008, Diagnosis and therapy of nonalcoholic steatohepatitis, Gastroenterology, 134, 1682, 10.1053/j.gastro.2008.02.077

Lazo, 2011, Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study, BMJ, 343, d6891, 10.1136/bmj.d6891

Schindhelm, 2007, Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients, Diabetes Care, 30, e94, 10.2337/dc07-0982

Szczepaniak, 2005, Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, Am J Physiol Endocrinol Metab, 288, E462, 10.1152/ajpendo.00064.2004

Williams, 2011, Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study, Gastroenterology, 140, 124, 10.1053/j.gastro.2010.09.038

Mensink, 2008, Diet and nonalcoholic fatty liver disease, Curr Opin Lipidol, 19, 25, 10.1097/MOL.0b013e3282f382ea

Bugianesi, 2005, A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease, Am J Gastroenterol, 100, 1082, 10.1111/j.1572-0241.2005.41583.x

Bugianesi, 2004, Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment, Best Pract Res Clin Gastroenterol, 18, 1105, 10.1016/S1521-6918(04)00086-1

Clark, 2006, Weight loss as a treatment for nonalcoholic fatty liver disease, J Clin Gastroenterol, 40, S39

Wagenknecht, 2011, Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study, Liver Int, 31, 412, 10.1111/j.1478-3231.2010.02444.x

Chung, 2010, Systematic review to support the development of nutrient reference intake values: challenges and solutions, Am J Clin Nutr, 92, 273, 10.3945/ajcn.2009.29092

Kirkham, 2010, The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews, BMJ, 340, c365, 10.1136/bmj.c365